Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,597,150
+$573,036 QoQ
Shares Held
979,847
+56.0% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,328,350,520 across 180 Biotechnology names. CDXS ranks #124 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in CDXS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,597,150 | 979,847 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,024,114 | 628,291 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $424,084 | 173,805 | Shares | Defined | 2025-11-14 | |
| 2024-06-30 | $164,377 | 53,025 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $591,826 | 169,578 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,778,970 | 911,138 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,025,670 | 1,600,884 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,253,897 | 1,876,392 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,452,226 | 1,316,963 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,313,917 | 1,354,918 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,183,524 | 525,334 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,655,651 | 445,091 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,038,463 | 292,845 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,788,564 | 89,177 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,871,022 | 166,424 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,611,188 | 159,364 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $978,524 | 42,749 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||